Most of the identified breakpoints of leukemia patients cluster to MLL introns 9–11 (~81%), and AF4 introns 3 and 4 (~86%), indicating that these regions of both genes are the preferred hotspots for the illegitimate recombination event. The gene discussed is KMT2A; the disease is leukemia.